Marcellomycin, a member of this complex, was selected for further study. Conditions for production of this antibiotic were developed in flask studies and scaled-up to the 3,000-liter fermentor stage. 
Materials and Methods
Strain C-36,145 was isolated from a soil sample from Ontario, Canada in the course of a screening program for discovery of new antitumor agents. Actinosporangium violaceum ATCC 15813, Streptomyces massasporeus ATCC 19785, and Actinopycnidium caerulium ATCC 15812 were obtained from the American Type Culture Collection, Rockville, Maryland. The procedures of SHIRLING and GOTTLIEB21) were used to characterize strain C-36,145 for taxonomic studies. The nitrate reduction test was described by GOTTLIEB22) and cell wall analysis was performed according to the procedures of YAMA-GUCHI23) and LECHEVALIER and LECHEVALIER24).
Cinerubin A and cinerubin B were obtained from the National Cancer Institute Bethesda, MD. Procedures for isolation of the bohemic acid complex from cultures of strain C-36,145 and the preparation of marcellomycin, musettamycin, pyrromycin, e-pyrromycinone and 7)-pyrromycinone are described by NETTLETON, et al. 4) Sterigmatocystin was prepared from cultures of Aspergillus versicolor M-107325).
For maintenance or fermentation studies strain C-36,145 was cultured on agar slant media consisting of either 2 g glucose, 20 g oatmeal, 2 g soy peptone and 20 g agar made up to one liter with distilled water, or 4 g glucose, 4 g yeast extract, 10 g malt extract and 20 g agar made up to one liter with distilled water. Slant cultures were incubated at 27°C for 144 hours. Spores and mycelium from a slant culture were transferred to 500-ml Erlenmeyer flasks containing 100 ml of sterile vegetative medium. A typical vegetative medium consists of 30 g glucose, 10 g soybean flour, 10 g Pharmamedia (Traders Oil Mill Co., Fort Worth, Texas) and 3 g CaCO3 made up to one liter with distilled water. The vegetative culture was incubated at 27°C for 48 hours on a rotary shaking machine (Gyrotory tier shaker, model G53 New Brunswick Scientific Co., Inc., New Brunswick, New Jersey) describing a 5.1-cm diameter circle. For the fermentation phase four ml of culture was transferred to a 500-ml flask containing 100 ml of sterile production medium and the culture was incubated on a similar shaker with prescribed experimental conditions.
Strain C-36,145 was cultivated in 14-liter stir jar fermentors containing ten liters of sterile production medium. Four hundred ml of vegetative culture was prepared as described previously and was transferred aseptically to the stir jar fermentor installed in a Fermentor Drive Assembly (Model FS-614, New Brunswick Scientific Co., New Brunswick, N.J.). The temperature was maintained at 27°C, the air flow rate was 6 liters/minute and the agitator was set at 360 rev/minute. Hodag Fl antifoam (Hodag Chemical Corp., Skokie, Illinois) was fed automatically as required to control foaming.
A 48-liter tank fermentor with 37.8 liters of production medium was inoculated with 1.89 liters of vegetative culture agitated with an impeller speed of 300 rev/minute, aerated at 85 liters/minute and incubated at 27°C. Hodag Fl antifoam was used to control foaming. A 3,800-liter tank fermentor with 3,000 liters of production medium was inoculated with 152 liters of vegetative culture, agitated with an impeller speed of 155 rev/minute, aerated at a rate of 1,400 liters/minute and incubated at 27°C. Polypropylene glycol was used to control foaming.
Clarified culture samples of strain C-36,145 were prepared for biological testing by centrifugation to remove mycelium. To prepare a mycelial extract, ten ml sample of culture was centrifuged and the supernatant was replaced with an equal volume of acetone. The mycelium was resuspended, shaken for thirty minutes on a reciprocal shaker and centrifuged to remove mycelium. A third procedure, designated a whole culture extract, consisted of extracting a culture sample for 30 minutes with an equal amount of acetone.
Antibiotic activity of culture samples, extracts and isolated bohemic acid components were measured with cylinder type agar diffusion assays. The assay organism, Bacillus subtilis ATCC 6633, was added as a spore suspension to Streptomycin Assay with Yeast Extract (Baltimore Biological Laboratory, Baltimore, Maryland). Assay plates were incubated at 30°C for 18 hours. A marcellomycin preparation, found by high pressure liquid chromatography) to be 98±% pure, was used as a standard and was given an assigned potency of 980 units/mg for the purpose of microbiological assays. To estimate marcellomycin content C-36,145 culture samples were extracted and the extract was analyzed by high pressure liquid chromatograph.
The procedure to test for induction of lysogenic Escherichia coli W1709 (i.) was described by BRADNER, et al.26) Phenobarbitol induced liver microsomes were obtained from Litton Bionetics Laboratory Products, Kensington, Maryland.
Thin-layer chromatography was carried out with 20 x 20 cm Uniplates precoated with a 250 ym layer of silica gel G (Analtech, Inc., Newark, Delaware). Bioautographs of thin-layer chromatograms with B. subtilis ATCC 6633 were prepared as described in an earlier publication"'.
Procedures for measurement of antitumor activity against lymphocytic leukemia P388 and L1210 leukemia and Walker 256 carcinosarcoma with test compounds have been described3). To test activity with clarified culture samples 0.5 ml of appropriate dilutions was administered daily for nine days. Gelatin is liquefied but casein is not hydrolyzed. Nitrate is reduced in CZAPEK'S medium. At 0.5 -4.0 % NaCl growth is moderate while at 8 % NaCl growth is negligible.
In Table 3 strain C-36,145 is compared with three actinomycete strains showing fused spore masses. Production of Antitumor and Antibiotic Activity with C-36,145 After isolation from soil, strain C-36,145 was cultured initially in medium 1 (Table 4) for four days in shake-flask culture. Undiluted culture fluid inhibited Walker 256 carcinosarcoma giving a 66 reduction in tumor growth compared to the control tumor group. With the same culture medium after incubation for five days activity was observed against the P388 tumor system with 1/8 and 1/16 dilutions SEPT. 1982 of culture fluid (Table 5) . When other media were tested with strain C-36,145 in flasks and tanks, improved production of antitumor activity was obtained (Table 5) .
Concomitant with increased antitumor activity, there was an increase in levels of antibiotic activity against Bacillus subtilis ATCC 6633. Both the extracellular fluid and acetone extracts of mycelium inhibited B. subtilis with agar diffusion assays (Table 6 ). Distilled water to
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Distilled water to Table 4 for medium composition .
** A value > _ 125 is considered significant antitumor activity.
A mixture of anthracycline antibiotics was isolated from flasks, stir-jars and tanks with strain C-36,145 cultured in media 1 -4 listed in Table 24 ).
Among the isolated antibiotics marcellomycin, a pyrromycinone triglycoside, was selected for further study. Therefore, conditions were developed to enhance production of marcellomycin specifically.
Culture extracts were chromatographed with a thin-layer system that separates marcellomycin from some but not all pyrromycinone glycosides (Table 7) . High pressure liquid chromatography is suitable to separate marcellomycin from other bohemic acid components and to quantitate marcellomycin content. In a flask culture with me- Table 6 . Distribution of antibiotic activity in extracellular fluid and mycelium of C-36,145 cultures*. Table 2 ) . ** Agar diffusion assays with Bacillus subtilis ATCC 6633 with marcellomycin as an assay standard (1 ,000 units/mg). *** Shaker speed . A yield of 160 lcg/ml was obtained at 118 hours in a 37-liter tank fermentation with medium 10. With the same medium the yield was 126 jtg/ml at 11 l hours in a 3,000-liter tank fermentation. Testing of Marcellomycin with Lysogenic Escherichia coli Strain W1709 (2) The antitumor activity of marcellomycin has been reported in detail28). Certain other antitumor anthracyclines such as daunomycin, adriamycin and carminomycin I induce lysogenic phage production with Escherichia coli (Table 8) . Therefore, marcellomycin was tested with and without treatment with microsomes for the property to induce bacteriophage. In Table 9 the data indicate that marcellomycin does not induce E. coli strain W1709 (2) with or without treatment with liver microsomes at levels as high as 370 Ftg/ml. The activity of sterigmatocystin is enhanced with liver microsomes at 1 mg/ml confirming the observation of MOREAU et al29). Mitomycin C induces E. coli strain W1709 (),)without microsomes and activity is reduced with microsomes. reddish orange diffusible pigments of the anthracycline type. HUSSEIN and KRASIL'NIKOV in 196932) described 33 actinomycete strains having smooth spores enclosed in mucous sporangia without a sporangial membrane. Each of these strains was distributed among four species, Actinosporangium calcenogenum, A. granulosum, A. violatum and A. aurantiacus, on the basis of the color of the substrate mycelium. All these strains were reported to have beige or dark beige aerial mycelium. On the other hand strain C-36,145 has grayish pink aerial mycelium.
Days of incubation
Streptomyces massasporeus strain 602 ATCC 1581335.36) and Actinopycnidium caerulium ATCC 1581237)38) reported to show fused spore masses were different from C-36,145 on yeast extract -malt extract agar in regard to color of aerial and substrate mycelium (Table 3) .
Since strain C-36,145 shows significant differences from those organisms previously described it is placed in a new species designated Actinosporangium bohemicum.
Phosphate stimulates production of cinerubins with Streptomyces griseorubiginosus9) and daunomycinone glycosides with Streptomyces sp.39) but inhibits marcellomycin production. With strain C-36,145 phosphate appears to enhance other bohemic acid components possibly cinerubin A and B at the expense of marcellomycin and rudolphomycin.
Since glucose and phosphate are commonly used in production media, this practice might explain why marcellomycin was not observed by other investigators examining cinerubin cultures with the exception of Streptomyces galilaeus MA 144-Ml ATCC 3113315)
Marcellomycin and other components in the bohemic acid complex do not induce E. coli strain W1709 (2) . Microsomal treatment, which can enhance inducing activity of sterigmatocystin, failed to have such an effect on marcellomycin. Conversely, daunomycin, adriamycin, carminomycin and the mixture of carminomycinone glycosides called figaroic acid complex40) were effective inducers without microsomal treatment (Table 8) . Other anthracyclines such as aklavinone glycosides, nogalomycin type, rhodomycin type and pyrromycinone glycosides also fail to induce E. coli strain WI709 (2). Aclacinomycin41) and marcellomycin42) are not mutagenic with Salmonella typhimurium tests while adriamycin is mutagenic41). All these findings are consistent with differing actions on nucleic acid synthesis. For example, adriamycin is more active than aclacinomycin in causing DNA cleavage43) whereas aclacinomycin and several pyrromycinone oligosaccharides cause greater inhibition of RNA synthesis, particularly nucleolar RNA synthesis, than adriamycin44).
The fact that marcellomycin had antitumor effects in several experimental systems, had a possibly more favorable toxicity profile as suggested by preliminary studies20,45) and a differing mechanism of action compared to adriamycin and daunomycin has lead to clinical trials of marcellomycin which are now underway.
